Increased risk of hyperlipidemia in patients with bipolar disorder: A population-based study

General Hospital Psychiatry

Volumn 37, Issue 4, 2015, Pages 294-298

  Hsu, Jer Hwa ^a   Chien, I Chia ^b,c   Lin, Ching Heng ^d  

^a Chia yi Hospital   (Taiwan)

^b Ministry of Health and Welfare   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Bipolar disorder; Hyperlipidemia; National Health Insurance; Prevalence; Taiwan

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BIPOLAR DISORDER; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEALTH INSURANCE; HIGH RISK POPULATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POPULATION RESEARCH; PREVALENCE; RISK ASSESSMENT; TAIWANESE; URBAN POPULATION; YOUNG ADULT; ADOLESCENT; HYPERLIPIDEMIAS; ODDS RATIO; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICAL MODEL; TAIWAN;

ANTILIPEMIC AGENT;

ADOLESCENT; ADULT; BIPOLAR DISORDER; DIABETES MELLITUS; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; HYPOLIPIDEMIC AGENTS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TAIWAN; YOUNG ADULT;

EID: 84930090887     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2015.04.003     Document Type: Article

References (40)

1. Fiedorowicz J.G., Palagummi N.M., Behrendtsen O., Coryell W.H. Cholesterol and affective morbidity. Psychiatry Res 2010, 175:78-81.
2. Chung K.H., Tsai S.Y., Lee H.C. Mood symptoms and serum lipids in acute phase of bipolar disorder in Taiwan. Psychiatry Clin Neurosci 2007, 61:428-433.
3. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359.
4. Chang H.Y., Yeh W.T., Chang Y.H., Tsai K.S., Pan W.H. Prevalence of dyslipidemia and mean blood lipid values in Taiwan: results from the Nutrition and Health Survey in Taiwan (NAHSIT, 1993-1996). Chin J Physiol 2002, 45:187-197.
5. Yeh C.J., Chang H.Y., Pan W.H. Time trend of obesity, the metabolic syndrome and related dietary pattern in Taiwan: from NAHSIT 1993-1996 to NAHSIT 2005-2008. Asia Pac J Clin Nutr 2011, 20:292-300.
6. Smith D.J., Nicholl B.I., Cullen B., Martin D., Ul-Haq Z., Evans J., et al. Prevalence and characteristics of probable major depression and bipolar disorder within UK Biobank: cross-sectional study of 172,751 participants. PLoS One 2013, 8:e75362.
7. Weissman M.M., Bland R.C., Canino G.J., Faravelli C., Greenwald S., Hwu H.G., et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996, 276:293-299.
8. Carney C.P., Jones L.E. Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. Psychosom Med 2006, 68:684-691.
9. Kilbourne A.M., Cornelius J.R., Han X., Pincus H.A., Shad M., Salloum I., et al. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord 2004, 6:368-373.
10. Crump C., Sundquist K., Winkleby M.A., Sundquist J. Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. JAMA Psychiatry 2013, 70:931-939.
11. Callaghan R.C., Khizar A. The incidence of cardiovascular morbidity among patients with bipolar disorder: a population-based longitudinal study in Ontario, Canada. J Affect Disord 2010, 122:118-123.
12. Chang H.H., Chou C.H., Chen P.S., Gean P.W., Huang H.C., Lin C.Y., et al. High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan. J Affect Disord 2009, 117:124-129.
13. Salvi V., D'Ambrosio V., Bogetto F., Maina G. Metabolic syndrome in Italian patients with bipolar disorder: a 2-year follow-up study. J Affect Disord 2012, 136:599-603.
14. McIntyre R.S., Danilewitz M., Liauw S.S., Kemp D.E., Nguyen H.T., Kahn L.S., et al. Bipolar disorder and metabolic syndrome: an international perspective. J Affect Disord 2010, 126:366-387.
15. Sicras A., Rejas J., Navarro R., Serrat J., Blanca M. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database. Bipolar Disord 2008, 10:607-616.
16. Salvi V., D'Ambrosio V., Rosso G., Bogetto F., Maina G. Age-specific prevalence of metabolic syndrome in Italian patients with bipolar disorder. Psychiatry Clin Neurosci 2011, 65:47-54.
17. Kilbourne A.M., Welsh D., McCarthy J.F., Post E.P., Blow F.C. Quality of care for cardiovascular disease-related conditions in patients with and without mental disorders. J Gen Intern Med 2008, 23:1628-1633.
18. Nasrallah H.A., Meyer J.M., Goff D.C., McEvoy J.P., Davis S.M., Stroup T.S., et al. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophr Res 2006, 86:15-22.
19. Chien I.C., Chou Y.J., Lin C.H., Bih S.H., Chou P. Prevalence of psychiatric disorders among National Health Insurance enrollees in Taiwan. Psychiatr Serv 2004, 55:691-697.
20. Chien I.C., Lin C.H., Chou Y.J., Chou P. Increased risk of hyperlipidemia in patients with major depressive disorder: a population-based study. J Psychosom Res 2013, 75:270-274.
21. Kleinbaum D.G., Kupper L.L., Morgensten H. Epidemiologic Research 1982, John Wiley & Sons, New York.
22. Hung Chi M., Hua Chang H., Tzeng N.S., Huang S.Y., Chou K.R., Chun Tsai H., et al. The prevalence of metabolic syndrome in drug-naive bipolar II disorder patients before and after twelve week pharmacological intervention. J Affect Disord 2013, 146:79-83.
23. Cerimele J.M., Katon W.J. Associations between health risk behaviors and symptoms of schizophrenia and bipolar disorder: a systematic review. Gen Hosp Psychiatry 2013, 35:16-22.
24. Slomka J.M., Piette J.D., Post E.P., Krein S.L., Lai Z., Goodrich D.E., et al. Mood disorder symptoms and elevated cardiovascular disease risk in patients with bipolar disorder. J Affect Disord 2012, 138:405-408.
25. Megna J.L., Schwartz T.L., Siddiqui U.A., Herrera Rojas M. Obesity in adults with serious and persistent mental illness: a review of postulated mechanisms and current interventions. Ann Clin Psychiatry 2011, 23:131-140.
26. Goldstein B.I., Liu S.M., Schaffer A., Sala R., Blanco C. Obesity and the three-year longitudinal course of bipolar disorder. Bipolar Disord 2013, 15:284-293.
27. Goldstein B.I., Kemp D.E., Soczynska J.K., McIntyre R.S. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. J Clin Psychiatry 2009, 70:1078-1090.
28. Kreinin A., Novitski D., Rabinowitz D., Weizman A., Grinshpoon A. Association between tobacco smoking and bipolar affective disorder: clinical, epidemiological, cross-sectional, retrospective study in outpatients. Compr Psychiatry 2012, 53:269-274.
29. Osby U., Brandt L., Correia N., Ekbom A., Sparen P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 2001, 58:44-850.
30. Hsu J.H., Chien I.C., Lin C.H., Chou Y.J., Chou P. Hyperlipidemia in patients with schizophrenia: a national population-based study. Gen Hosp Psychiatry 2012, 34:360-367.
31. Birkenaes A.B., Opjordsmoen S., Brunborg C., Engh J.A., Jonsdottir H., Ringen P.A., et al. The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. J Clin Psychiatry 2007, 68:917-923.
32. Correll C.U., Frederickson A.M., Kane J.M., Manu P. Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics. Bipolar Disord 2008, 10:788-797.
33. Soreca I., Fagiolini A., Frank E., Houck P.R., Thompson W.K., Kupfer D.J. Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder. J Psychiatr Res 2008, 42:956-961.
34. Frontini M.G., Srinivasan S.R., Elkasabany A., Berenson G.S. Awareness of hypertension and dyslipidemia in a semirural population of young adults: the Bogalusa Heart Study. Prev Med 2003, 36:398-402.
35. Grundy S.M. Atherogenic dyslipidemia associated with metabolic syndrome and insulin resistance. Clin Cornerstone 2006, 8:S21-S27.
36. Chien I.C., Chang K.C., Lin C.H., Chou Y.J., Chou P. Prevalence of diabetes in patients with bipolar disorder in Taiwan: a population-based national health insurance study. Gen Hosp Psychiatry 2010, 32:577-582.
37. Chien I.C., Lin C.H., Chou Y.J., Chou P. Risk of hypertension in patients with bipolar disorder in Taiwan: a population-based study. Compr Psychiatry 2013, 54:687-693.
38. Hsu P.F., Chuang S.Y., Cheng H.M., Tsai S.T., Chou P., Chen C.H. Clinical significance of the metabolic syndrome in the absence of established hypertension and diabetes: a community-based study. Diabetes Res Clin Pract 2008, 79:461-467.
39. Chang H.H., Yang Y.K., Gean P.W., Huang H.C., Chen P.S., Lu R.B. The role of valproate in metabolic disturbances in bipolar disorder patients. J Affect Disord 2010, 124:319-323.
40. Olfson M., Marcus S.C., Corey-Lisle P., Tuomari A.V., Hines P., L'Italien G.J. Hyperlipidemia following treatment with antipsychotic medications. Am J Psychiatry 2006, 163:1821-1825.